Neoplasm Metastasis clinical trials
The registry lists 4,048 studies for Neoplasm Metastasis across more than 10 countries. 891 are recruiting or about to start. 1,468 of them are mainly about Neoplasm Metastasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17. Counting its 3 narrower conditions too, such as Neoplastic Cells, Circulating: 4,552 studies, 1,032 open.
ClinicalTrials.gov finds 22,901 studies for Neoplasm Metastasis. How that becomes 4,045 here
This page counts the studies the registry files under Neoplasm Metastasis, and those it files under no condition that list Neoplasm Metastasisthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 15, 2026. How condition pages count
- 22,901Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −503Filed under a narrower condition, counted on its own pageNeoplastic Cells, Circulating 207 · Lymphatic Metastasis 202 · Neoplasms, Unknown Primary 94
- −1,312List Neoplasm Metastasis as a condition, but the registry did not file them under itMost often written as “Brain Metastases” (328), “Liver Metastases” (208), and “Bone Metastases” (79). The registry filed 14 of them under no condition at all, and the others under other conditions only, most often Brain Neoplasms (474) and Colorectal Neoplasms (210).
- −17,163Match it another way1,316 name it in the title, 243 in a keyword, and 15,604 by a synonym or other text the search reads.
- 3,923Counted here and found by its search317 of them list Neoplasm Metastasis in their own words; the registry filed them under no condition.
- +122
Counted here, but its search does not find them
- A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation TherapyNCT05155423
- Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal LesionsNCT04242589
- Magnetic Resonance Imaging-guided Online Adaptive Radiotherapy of Pelvic Lymph Node MetastasesNCT07083648
- Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone MetastasesNCT01470105
- Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic DiseaseNCT05101824
- PK/PD Study of SHR-2017 Injection in Patients With Bone MetastasesNCT06380881
- Quantitative MRI for Functional Assessment Following SBRT for Spinal MetastasesNCT04248543
- Measuring Fatty Acid Oxidation in Cerebral Metastases Using [18F]FPIANCT04807582
- Multicentric European Study In Patients With Vertebral MetastasesNCT06220071
- Stereotactic Body Radiation Therapy (SBRT) for Liver MetsNCT01360606
- Palliation: the Effect of Education on PainNCT01358539
- Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal MetastasesNCT02512965
- Randomized Trial Comparing Conventional Radiotherapy With Stereotactic Radiotherapy in Patients With Bone Metastases - VERTICAL StudyNCT02364115
- Study of Different Gating Techniques for PET Image of Lung and Liver LesionsNCT05779865
- Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone MetastasesNCT01248585
- Prospecitve Observational Study on a Risk Adaptive Scheme for SBRT for Thoracic Nodes MetastasesNCT02970955
- Feasibility of Preoperative Inspiratory Muscle Training for Patients With Peritoneal MetastasesNCT05665257
- Biological Imaging Guided Antalgic Radiotherapy of Bone Metastases (Phase II Trial)NCT00503178
- Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone MetastasesNCT01429493
- Validation of Novel Predictive Score for Patients With Spinal MetastasesNCT03224650
- 4,045The count on this page
Get an email when these change. Save the Neoplasm Metastasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Status
Who runs them
M.D. Anderson Cancer Center (135) · National Cancer Institute (NCI) (124) · Eli Lilly and Company (72) · Memorial Sloan Kettering Cancer Center (61) · AstraZeneca (54) · Novartis Pharmaceuticals (43) · Pfizer (42) · Fudan University (40)
What is being tested here
Drugs under test in Neoplasm Metastasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Drug classes tested here Immune checkpoint inhibitors 47 open · Tyrosine kinase inhibitors (TKIs) 43 open · Antibody-drug conjugates (ADCs) 21 open · Antimetabolites 18 open · Angiogenesis inhibitors 8 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC) · Phase 3 · Qilu Pharmaceutical Co., Ltd.
- Dec 2026A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy · Phase 3 · M.D. Anderson Cancer Center
- Dec 2026Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer · Phase 3 · M.D. Anderson Cancer Center
- Dec 2026A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC · Phase 3 · Sun Yat-sen University
- Mar 2027Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma · Phase 3 · TuHURA Biosciences, Inc.
- Mar 2027Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases · Phase 3 · Sun Yat-sen University
- Apr 2027Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy. · Phase 3 · Taiho Oncology, Inc.
- Apr 2027Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma · Phase 3 · mAbxience Research S.L.
- Apr 2027Metastasis-directed Therapy for Oligorecurrent Prostate Cancer · Phase 3 · Universitaire Ziekenhuizen KU Leuven
- May 2027Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09) · Phase 3 · AstraZeneca
Who these studies take
Of the 691 Neoplasm Metastasis studies recruiting now, 538 (78%) set no upper age limit and 97 (14%) stop at 75 or younger. 48 (7%) take children under 18. 35 (5%) are for women only and 27 (4%) for men only; 18 (3%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 28 (4%) | 30 (4%) |
| 18 | 641 (93%) | 631 (91%) |
| 30 | 656 (95%) | 646 (93%) |
| 40 | 654 (95%) | 645 (93%) |
| 50 | 650 (94%) | 643 (93%) |
| 65 | 647 (94%) | 641 (93%) |
| 75 | 625 (90%) | 623 (90%) |
| 85 | 543 (79%) | 552 (80%) |
Across all 4,048 studies, recruiting or not: 11% stop at 75 or younger and 2% at 65; 7% take children; 8% are for women only and 5% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Neoplasm Metastasis studies take
Of 498 phase 1 interventional studies under Neoplasm Metastasis, half reached primary completion within 54 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 54 mo33–83 · 498 studies | 48 mo28–75 · 288 studies | 62 mo40–98 · 210 studies |
| Phase 1/2 | 62 mo41–89 · 213 studies | 56 mo41–89 · 127 studies | 65 mo43–90 · 86 studies |
| Phase 2 | 56 mo33–83 · 443 studies | 33 mo26–63 · 88 studies | 60 mo36–90 · 355 studies |
| Phase 2/3 | 56 mo43–98 · 27 studies | — | — |
| Phase 3 | 49 mo36–66 · 138 studies | 41 mo34–57 · 83 studies | 59 mo49–108 · 55 studies |
| Phase 4 | 53 mo22–68 · 24 studies | — | — |
| Interventional, no phase | 54 mo28–91 · 316 studies | — | 58 mo28–93 · 291 studies |
| Observational | 66 mo35–172 · 242 studies | — | 75 mo36–172 · 211 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 18, 2026.
Started recruiting13
- First-line Treatment in Locally Advanced or Metastastic Small Bowel AdenocarcinomaNov 16, 2026NCT07844057
- Validation of the G8 Screening Tool for Prognostic Assessment of Frailty and Early Mortality in Elderly Individuals With Cancer: Prospective Cohort Study in BrazilNov 13, 2026NCT07773285
- Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver MetastasesNov 12, 2026NCT07406126
- A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard TherapyNov 10, 2026NCT07423117
- Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic CancerNov 6, 2026NCT07829185
Show 8 moreShow fewer
- Estimating the Impact of Sexuality Education and Mobile Health Services on Reproductive Health and Empowerment Among Adolescents in Sierra Leone for the Family Planning Impact LabNov 6, 2026NCT07860723
- Change in Fat Fraction Quantification Before and After Treatment in Bone MetastasesNov 4, 2026NCT07848516
- Pilot Study of TumorGlow for Intraoperative Molecular Imaging of Sarcoma Metastases to the Lungs in Pediatric PatientsNov 2, 2026NCT07658768
- Pluvicto Real-world Investigation in Survival in Metastatic CRPCOct 30, 2026NCT07697989
- Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Oct 28, 2026NCT04886804
- Biology-Guided Radiation Therapy for the Treatment of Patients With Bone MetastasesOct 28, 2026NCT06549478
- Biopsy-Resection Agreement of Peritoneal Histopathological Growth Patterns in Colorectal Peritoneal Metastases: A Prospective Observational Pilot StudyOct 26, 2026NCT07474025
- A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast CancerOct 21, 2026NCT07658183
Results posted6
- Testing the Biological Effects of DS-8201a on Patients With Advanced CancerNov 17, 2026NCT04294628
- LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid TumorsNov 16, 2026NCT04666688
- Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseNov 5, 2026NCT01552434
- Radiosensitizing Chemotherapy withSBRT for the Treatment of Inoperable Liver and/or Lung Metastases of CRCOct 30, 2026NCT01220063
- Genetic Testing in Guiding Treatment for Patients With Brain MetastasesOct 30, 2026NCT03994796
Stopped4
- AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)TerminatedNov 16, 2026NCT07285694
- Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With TebentafuspWithdrawnNov 6, 2026NCT07803562
- FS120 Phase 1/1b Study in Patients With Advanced MalignanciesTerminatedNov 5, 2026NCT04648202
- CT-95 in Advanced Cancers Associated With Mesothelin ExpressionTerminatedNov 5, 2026NCT06756035
Newly registered25
- A Multicenter, Open-label, Phase 1/1b, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SI-B037 in Solid TumorsNov 17, 2026NCT07940881
- Remote Exercise iNtErvention for Wellbeing (RENEW) TrialNov 17, 2026NCT07942064
- DYNAMIC Pilot Optimization TrialNov 16, 2026NCT07937423
- Induction Trastuzumab Rezetecan Followed by Maintenance Dalpiciclib and Endocrine Therapy as First-line Treatment of HR+/HER2 Low mBCNov 13, 2026NCT07935226
- Liver Tumor Microenvironment Remodeling Promotes Hepatocellular Carcinoma ProgressionNov 13, 2026NCT07937137
Show 20 moreShow fewer
- Phase 1b/2 to Evaluate the Safety, Tolerability, and Efficacy of TXN10128 in Combination With TOPO-I Inhibitor-based Therapies (Irinotecan or TROP2 ADC) in Advanced or Metastatic EGFR Mutated NSCLCNov 12, 2026NCT07933055
- Liver Metastasis in Pancreatic Ductal Adenocarcinoma: Regulatory Mechanisms and Clinical SignificanceNov 12, 2026NCT07933952
- LIMA1 Immunohistochemistry and Depth of Invasion as Prognostic Biomarkers in Oral Squamous Cell CarcinomaNov 12, 2026NCT07934316
- A Study of Real-world Effectiveness of 177Lu-PSMA-617 With and Without Concurrent Androgen Receptor Pathway Inhibitors in Metastatic Castration Resistant Prostate Cancer PatientsNov 10, 2026NCT07928037
- Lenvatinib And Stereotactic radiothErapy With pembRolizumab in Metastatic Kidney Cancer PatientsNov 10, 2026NCT07928167
- A Multicenter, Prospective Single-arm Study of Multimodal Thermal Therapy Combined With Toripalimab and AG Chemotherapy in the Treatment of Advanced Pancreatic CancerNov 10, 2026NCT07928362
- Effect of Squatting Position in the Second Stage of Labor on Birth OutcomesNov 5, 2026NCT07918872
- Ultrasonographic Tissue Thickness After Complex Decongestive Therapy in Lower-Limb LymphedemaNov 5, 2026NCT07919834
- Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient Clinic of the Clinical Unit of Endocrinology at the Modena University Hospital (AOU Modena)Nov 5, 2026NCT07920198
- CR-002 in Adult Participants With Locally Advanced or Metastatic Solid TumorsNov 2, 2026NCT07909031
- Station-Specific Lymph Node Metastasis After Neoadjuvant Chemoimmunotherapy for Middle Thoracic Esophageal Squamous Cell CarcinomaOct 29, 2026NCT07902544
- A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.Oct 29, 2026NCT07903415
- Impact of a Radiologic and Immunologic Signature on Cerebral Efficacy of Treatments in Lung Cancers With Brain MetastasisOct 29, 2026NCT07904013
- Immune-Related Adverse Events and Clinical Outcomes of First-Line Immunotherapy in Egyptian Patients With Unresectable Hepatocellular CarcinomaOct 29, 2026NCT07904494
- Study of Trastuzumab Deruxtecan in Combination With Stereotactic Radiosurgery in Patients With HER2-Positive Metastatic Breast Cancer and First Diagnosis of Brain Metastases (HERBRAIN)Oct 29, 2026NCT07905313
- A Retrospective Registry of Intelliblate DUAL Channel Microwave AblationOct 28, 2026NCT07900984
- Aspirin and PAClitaxel in Head & Neck Squamous Cell CarcinomaOct 28, 2026NCT07901803
- ESR1 Mutations in Metastatic Hormone Receptor-Positive Breast Cancer in the Greek PopulationOct 27, 2026NCT07899463
- A Study of MDSY-1240, a STAT3 Degrader, for the Treatment of Hematologic Malignancies and Advanced Solid TumorsOct 27, 2026NCT07899632
- An Investigational Study of BON-106 in Adults With Advanced or Metastatic Solid TumorsOct 26, 2026NCT07893535
Studies
Recruiting first, then most recently updated. Showing 50 of 4,048. Browse all 4,048 → or search them.
- Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump TherapyNot yet recruitingNCT07715903Phase 11 country
- Pelvic Floor Ultrasound Before Induction of Labour and Labour OutcomeNot yet recruitingNCT077973871 country
- The STRONG Nutrition Support Study for People With Pancreatic CancerNot yet recruitingNCT07826780Not applicable1 country
- A Multicenter, Open-label, Phase 1/1b, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SI-B037 in Solid TumorsRecruitingNCT07940881Phase 11 country
- SLR-108 PET Imaging in Subjects With Advanced CancerRecruitingNCT07728942Phase 11 country
- Remote Exercise iNtErvention for Wellbeing (RENEW) TrialNot yet recruitingNCT07942064Phase 21 country
- HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsRecruitingNCT03911388Phase 11 country
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCRecruitingNCT06216301Phase 317 countries
- A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsRecruitingNCT07277413Phase 12 countries
- First-line Treatment in Locally Advanced or Metastastic Small Bowel AdenocarcinomaRecruitingNCT07844057Phase 21 country
- A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.RecruitingNCT07903415Phase 11 country
- A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT06983743Phase 13 countries
- Neurocognition in Patients With Multiple Brain Metastases Treated With RadiosurgeryRecruitingNCT03184038Not applicable1 country
- DYNAMIC Pilot Optimization TrialNot yet recruitingNCT07937423Not applicable1 country
- Validation of the G8 Screening Tool for Prognostic Assessment of Frailty and Early Mortality in Elderly Individuals With Cancer: Prospective Cohort Study in BrazilRecruitingNCT077732851 country
- CR-001 in Adult Participants With Locally Advanced or Metastatic Solid TumorsRecruitingNCT07335497Phase 1/210 countries
- Liver Tumor Microenvironment Remodeling Promotes Hepatocellular Carcinoma ProgressionNot yet recruitingNCT07937137
- A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal CancerRecruitingNCT07693751Phase 1/23 countries
- Induction Trastuzumab Rezetecan Followed by Maintenance Dalpiciclib and Endocrine Therapy as First-line Treatment of HR+/HER2 Low mBCNot yet recruitingNCT07935226Phase 2
- Phase 1b/2 to Evaluate the Safety, Tolerability, and Efficacy of TXN10128 in Combination With TOPO-I Inhibitor-based Therapies (Irinotecan or TROP2 ADC) in Advanced or Metastatic EGFR Mutated NSCLCRecruitingNCT07933055Phase 1/21 country
- Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 GeneRecruitingNCT05372614Phase 11 country
- A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) MutationRecruitingNCT07458347Phase 11 country
- Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver MetastasesRecruitingNCT074061261 country
- Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral MetastasesRecruitingNCT04218617Phase 21 country
- Liver Metastasis in Pancreatic Ductal Adenocarcinoma: Regulatory Mechanisms and Clinical SignificanceRecruitingNCT079339521 country
- LIMA1 Immunohistochemistry and Depth of Invasion as Prognostic Biomarkers in Oral Squamous Cell CarcinomaEnrolling by invitationNCT079343161 country
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialRecruitingNCT05564377Phase 22 countries
- Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)RecruitingNCT04886804Phase 118 countries
- Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)AvailableNCT05650476
- Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid TumorsRecruitingNCT05372640Phase 11 country
- AZD5305 hADME in Patients With Advanced Solid MalignanciesRecruitingNCT06713369Phase 11 country
- Harvesting Cells for Experimental Cancer TreatmentsEnrolling by invitationNCT000680031 country
- The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid CancerRecruitingNCT04927416Phase 21 country
- Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast CancerRecruitingNCT05111561Phase 11 country
- Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver MetastasesRecruitingNCT05195710Phase 11 country
- Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian CancerRecruitingNCT04585958Phase 11 country
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsRecruitingNCT06270706Phase 12 countries
- Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesRecruitingNCT04907643Not applicable1 country
- Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone MetastasesRecruitingNCT06391242Phase 31 country
- Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ TrialRecruitingNCT03907475Phase 21 country
- A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsRecruitingNCT07020221Phase 1/24 countries
- A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1RecruitingNCT07292168Phase 1/21 country
- A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard TherapyRecruitingNCT07423117Phase 11 country
- Lenvatinib And Stereotactic radiothErapy With pembRolizumab in Metastatic Kidney Cancer PatientsRecruitingNCT07928167Phase 21 country
- A Multicenter, Prospective Single-arm Study of Multimodal Thermal Therapy Combined With Toripalimab and AG Chemotherapy in the Treatment of Advanced Pancreatic CancerNot yet recruitingNCT07928362Not applicable1 country
- A Study of Real-world Effectiveness of 177Lu-PSMA-617 With and Without Concurrent Androgen Receptor Pathway Inhibitors in Metastatic Castration Resistant Prostate Cancer PatientsNot yet recruitingNCT07928037
- BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial Cancer After Progression on Anti-PD-(L)1-based TherapyRecruitingNCT07869836Phase 31 country
- Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract CancerNot yet recruitingNCT07793253Phase 21 country
- ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerRecruitingNCT07007559Phase 28 countries
- Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid TumorsRecruitingNCT05394103Phase 1/22 countries